Maywufa CoTPE:1731 86 PB Ratio is 1.27 as of Jul. 12, 2026, which is 2% above its 10-year median of 1.25. GuruFocus rates TPE:1731 with a GF Score™ of 86/100 and a GF Value™ of NT$26.79 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 925 Drug Manufacturers companies, Maywufa Co ranks better than 67.03% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-12), Maywufa Co's share price is NT$20.65. Maywufa Co's Book Value per Share for the quarter that ended in Dec. 2025 was NT$16.27. Hence, Maywufa Co's PB Ratio of today is 1.27.
Good Sign:
Maywufa Co Ltd stock PB Ratio (=1.27) is close to 3-year low of 1.27.
The historical rank and industry rank for Maywufa Co's PB Ratio or its related term are showing as below:
TPE:1731'
s PB Ratio Range Over the Past 10 Years
Min: 0.9 Med: 1.25 Max: 1.74
Current: 1.27
During the past 13 years, Maywufa Co's highest PB Ratio was 1.74. The lowest was 0.90. And the median was 1.25.
TPE:1731's PB Ratio is ranked better than 67.03% of 925
companies
in the Drug Manufacturers industry
Industry Median: 1.91
vs TPE:1731: 1.27
During the past 12 months, Maywufa Co's average Book Value Per Share Growth Rate was 2.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 2.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 2.60% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Maywufa Co was 5.30% per year. The lowest was -0.20% per year. And the median was 1.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Maywufa Co PB Ratio Related Terms
Maywufa Co PB Ratio Historical Data
* Premium members only.
The historical data trend for Maywufa Co's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Maywufa Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maywufa Co PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Maywufa Co's PB Ratio distribution charts can be found below:
* The bar in red indicates where Maywufa Co's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Maywufa Co's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Maywufa Co (TPE:1731) has a PB Ratio of 1.27 as of Jul. 12, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Maywufa Co and its competitors. This is near median its historical median of 1.25. Over the past decade, Maywufa Co's PB Ratio has ranged from 0.90 to 1.74. According to the industry distribution chart, Maywufa Co ranks #305 out of 925 companies in the Drug Manufacturers industry, placing it in the top 33%.
Is Maywufa Co's PB Ratio too high?
Maywufa Co's current PB Ratio of 1.27 is near median its 10-year median of 1.25. Over the past 10 years, this metric has ranged from a low of 0.90 to a high of 1.74. The Drug Manufacturers industry median PB Ratio is 1.91. Maywufa Co's value of 1.27 is 33.5% below this industry median. Based on the distribution chart, Maywufa Co ranks #305 out of 925 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Maywufa Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Maywufa Co's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Maywufa Co ranks #305 out of 925 companies for PB Ratio. This puts Maywufa Co in the upper half of its industry. The industry median PB Ratio is 1.91. Maywufa Co's value of 1.27 is 33.5% below this benchmark. Historically, Maywufa Co's own PB Ratio has ranged from 0.90 to 1.74 over the past decade. While the company's 10-year median is 1.25 vs. the industry median of 1.91, Maywufa Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.91, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maywufa Co's current PB Ratio of 1.27 is 33.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Maywufa Co and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maywufa Co's current PB Ratio is 1.27, which is near median its own 10-year median of 1.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maywufa Co stock overvalued right now?
Based on GuruFocus' analysis, Maywufa Co (TPE:1731) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$26.79, compared to a current price of NT$20.65 — trading 22.9% below its estimated fair value. The current PB Ratio is 1.27, which is near median its 10-year median of 1.25 and 33.5% below the Drug Manufacturers industry median of 1.91. Maywufa Co's overall GF Score™ is 86/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Maywufa Co (TPE:1731), the current PB Ratio is 1.27 as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maywufa Co (TPE:1731) Overvalued in 2026?
Based on GuruFocus' analysis, Maywufa Co stock appears to be undervalued.
The current stock price of NT$20.65 is trading 22.9% below its estimated GF Value™ of NT$26.79.
GuruFocus considers Maywufa Co to be Modestly Undervalued.
Key valuation signals for TPE:1731:
PB Ratio: 1.27 (near median its 10-year median of 1.25)
GF Value™: NT$26.79 vs. price of NT$20.65 (22.9% below fair value)
Industry Position: 33.5% below the Drug Manufacturers median (#305 of 925)
No single metric tells the full story. See the TPE:1731 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Maywufa Co Ltd operates as a drug manufacturer. The company is engaged in manufacturing of hair and skin care products. The company has two reportable segments segments: Management Department, Consumer Business Unit, and Pharmaceutical Business Unit. It derives maximum revenue from Pharmaceutical Business Unit.
86GF Score
Get the complete analysis for TPE:1731
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1731 has been successfully added to your 
